DE60042922D1 - Virale expressionsvektoren für pflanzen - Google Patents

Virale expressionsvektoren für pflanzen

Info

Publication number
DE60042922D1
DE60042922D1 DE60042922T DE60042922T DE60042922D1 DE 60042922 D1 DE60042922 D1 DE 60042922D1 DE 60042922 T DE60042922 T DE 60042922T DE 60042922 T DE60042922 T DE 60042922T DE 60042922 D1 DE60042922 D1 DE 60042922D1
Authority
DE
Germany
Prior art keywords
altered
plants
movement protein
expression vectors
viral expression
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60042922T
Other languages
German (de)
English (en)
Inventor
Wayne P Fitzmaurice
Gregory P Pogue
John A Lindbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KENTUCKY BIOPROC OWENSBORO LLC
Original Assignee
KENTUCKY BIOPROC OWENSBORO LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KENTUCKY BIOPROC OWENSBORO LLC filed Critical KENTUCKY BIOPROC OWENSBORO LLC
Application granted granted Critical
Publication of DE60042922D1 publication Critical patent/DE60042922D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/00041—Use of virus, viral particle or viral elements as a vector
    • C12N2770/00043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE60042922T 1999-05-04 2000-05-04 Virale expressionsvektoren für pflanzen Expired - Lifetime DE60042922D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13269799P 1999-05-04 1999-05-04
PCT/US2000/012380 WO2000066743A2 (en) 1999-05-04 2000-05-04 Viral expression vectors

Publications (1)

Publication Number Publication Date
DE60042922D1 true DE60042922D1 (de) 2009-10-22

Family

ID=22455189

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60042922T Expired - Lifetime DE60042922D1 (de) 1999-05-04 2000-05-04 Virale expressionsvektoren für pflanzen

Country Status (13)

Country Link
US (2) US6656726B1 (enExample)
EP (1) EP1181372B1 (enExample)
JP (1) JP4750285B2 (enExample)
KR (1) KR20020000802A (enExample)
AT (1) ATE442441T1 (enExample)
AU (1) AU781020B2 (enExample)
BR (1) BR0010222A (enExample)
CA (1) CA2373026C (enExample)
DE (1) DE60042922D1 (enExample)
ES (1) ES2332982T3 (enExample)
IL (1) IL146191A0 (enExample)
WO (1) WO2000066743A2 (enExample)
ZA (1) ZA200108528B (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE442441T1 (de) 1999-05-04 2009-09-15 Kentucky Bioproc Llc Virale expressionsvektoren für pflanzen
US20080160040A1 (en) * 2004-04-15 2008-07-03 Ghim Shin-Je Plant-produced compositions for treating papillomavirus infection and related methods
MY144766A (en) * 2004-12-30 2011-10-31 Schering Plough Ltd Plant virus coat fusion proteins with gdf8 epitopes and vaccines thereof
CA2621466A1 (en) * 2005-09-08 2007-04-05 Kentucky Bioprocessing, Llc Modified tobacco mosaic virus particles as scaffolds for display of protein antigens for vaccine applications
WO2008094512A2 (en) * 2007-01-29 2008-08-07 The Ohio Sate University Research Foundation System for expression of genes in plants from a virus-based expression vector
WO2014097733A1 (ja) * 2012-12-21 2014-06-26 株式会社ＵｎｉＢｉｏ ヒト上皮細胞増殖因子の製造方法
US11820988B2 (en) * 2019-02-28 2023-11-21 Purdue Research Foundation Nanoparticles and biotemplates with tunable length and methods of manufacturing the same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5977438A (en) 1988-02-26 1999-11-02 Biosource Technologies, Inc. Production of peptides in plants as viral coat protein fusions
US5316931A (en) 1988-02-26 1994-05-31 Biosource Genetics Corp. Plant viral vectors having heterologous subgenomic promoters for systemic expression of foreign genes
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5412087A (en) 1992-04-24 1995-05-02 Affymax Technologies N.V. Spatially-addressable immobilization of oligonucleotides and other biological polymers on surfaces
IL108241A (en) 1992-12-30 2000-08-13 Biosource Genetics Corp Plant expression system comprising a defective tobamovirus replicon integrated into the plant chromosome and a helper virus
WO1995021248A1 (en) 1994-02-03 1995-08-10 The Scripps Research Institute Method for using tobacco mosaic virus to overproduce peptides and proteins
US5695937A (en) 1995-09-12 1997-12-09 The Johns Hopkins University School Of Medicine Method for serial analysis of gene expression
US5816653A (en) 1997-03-17 1998-10-06 Schukra Of North America Ltd. Apparatus and method for adjusting the position of a supporting element in a seat
ATE442441T1 (de) 1999-05-04 2009-09-15 Kentucky Bioproc Llc Virale expressionsvektoren für pflanzen

Also Published As

Publication number Publication date
CA2373026A1 (en) 2000-11-09
WO2000066743A2 (en) 2000-11-09
ES2332982T3 (es) 2010-02-16
AU4824700A (en) 2000-11-17
CA2373026C (en) 2011-05-03
AU781020B2 (en) 2005-04-28
WO2000066743A3 (en) 2001-04-26
BR0010222A (pt) 2002-03-19
KR20020000802A (ko) 2002-01-05
US7132588B2 (en) 2006-11-07
US20050175590A1 (en) 2005-08-11
US6656726B1 (en) 2003-12-02
ZA200108528B (en) 2002-10-17
JP2002542828A (ja) 2002-12-17
ATE442441T1 (de) 2009-09-15
WO2000066743A9 (en) 2002-03-14
EP1181372B1 (en) 2009-09-09
JP4750285B2 (ja) 2011-08-17
EP1181372A2 (en) 2002-02-27
IL146191A0 (en) 2002-07-25

Similar Documents

Publication Publication Date Title
ES2664505T3 (es) Secuencias de serotipo 9 de virus adeno-asociado (AAV), vectores que las contienen, y usos de las mismas
HUP0301659A2 (hu) Kukorica cellulóz-szintetázok és alkalmazásuk
FR19C1020I1 (fr) Nouvelles molecules b7-4 et leurs utilisations
NO20030621L (no) Anti-dual integrinantistoffer, sammensetninger, fremgangsmater og anvendelser
ATE270342T1 (de) Endosomolytisch wirksame partikel
ATE500323T1 (de) Subtilisin-variante
ATE366814T1 (de) Gl50 moleküle, sowie verwendungen derselben
DK0561890T3 (da) DNA ekspressionssystemer baseret på alphavira
DE60128149D1 (en) Putrescin-n-methyltransferasepromotor
DE60041243D1 (de) Gebrauchsverfaheren eines neuen lysyloxidase-verwandten proteins
WO2002079239A3 (en) Chimeric filovirus glycoprotein
ATE442441T1 (de) Virale expressionsvektoren für pflanzen
ATE363070T1 (de) Auswertung von biologischen mitteln in lebenden zielzellen
EP1412374A4 (en) NEW PGC-1 ISOFORMS AND THEIR USES
ATE323767T1 (de) Impfstoff für die infektiöse peritonitis der katzen
ATE406446T1 (de) Vermehrungsproteine von pflanzen
WO2002083896A3 (en) Recombinant segmented negative strand virus with a duplicated 3' noncoding flanking sequence, and therapeutic compositions containing the same
ATE470716T1 (de) 18480 humane proteinkinasemoleküle und ihre verwendungen
WO2001049712A3 (en) Vaccine against isav (infectious salmon anaemia virus)
DK1328621T3 (da) 13245, en ny human proteinkinase af den myotoniske dystrofitype og anvendelser deraf
WO2005007827A3 (en) Avian adeno-associated virus vector
WO2001081584A3 (en) 27960, a novel ubiquitin conjugating enzyme family member and uses therefor
DE60330140D1 (de) Gen-silencing-vektor und diesen verwendendes gen-silencing-verfahren
DE60136832D1 (de) Atcr-1, eine humane acyltransferase und verwendungen davon
DE60124910D1 (de) Menschliche twik-8 moleküle und ihre verwendung

Legal Events

Date Code Title Description
8364 No opposition during term of opposition